|
Information About Ortho Tri-cyclen - Birth Control Articles Medical Health
|
Barr Laboratories, Inc., (BRL) had announced that it has settled the litigation that was pending about Ortho-McNeil Pharmaceutical, Inc., for the protection of patent of Ortho Tri-Cyclen that was the patent of Ortho-McNeil Pharmaceutical, Inc. Now Barr laboratories have started shipping their product that is the generic version of Ortho Tri-Cyclen manufactured by Ortho-McNeil Pharmaceutical, Inc. the generic version will be sold under the Tri-Sprintec trademark. It is said that Barr laboratories became able to enter into the market three months earlier because of the terms of the settlement with Ortho-McNeil Pharmaceutical. The terms of the settlement had permitted the Barr laboratories for the introduction of the generic version of Ortho Tri-Cyclen on December 29, 2003. Barr laboratories have received significant financial opportunity as their Tri-Sprintec oral contraceptive product has been approved and launched. The current portfolio of their generic oral contraceptive has been increased to 18 products that are able for the competition in the $ 3.1 billion contraceptive marketplace. This increase is also due to the approval and launching of the Tri-Sprintec oral contraceptive drug. Ortho Tri-Cyclen is considered as a regimen of oral contraceptives in which three different tablets are included in combinations of ethinyl estradiol and norgestimate. This drug is used for the prevention of pregnancy. Women who do not want to be pregnant electively use this product. A packet of the product consists of 28-tablets. The annual sales of the product for the twelve months that were ending in October 2003 was found to be approximately $ 716 million. Buy Phentermine Cheap Phentermine Order Phentermine Phentermine online Phentermine Cheap Phentermine Herbal Diet Pills adipex phentermine diet pills |
